Locally Invasive Prostate Cancer
作者： Craig D. Zippe , Anurag W. Kedia
DOI: 10.1007/978-1-59259-714-7_13
关键词:
摘要: Since 1993, the incidence of clinical T3 prostate cancer has been reported to be 10% all newly diagnosed cancers annually (1). However, prior era PSA screening, comprised nearly 20–30% (2,3). In pre-prostate-specific antigen (PSA) era, treatment outcomes frequently involved an initial monotherapy approach (either radical surgery or radiation therapy [RT]) with subsequent salvage a failure secondary therapy. Analysis results from this using as evidence for biochemical revealed unexpected high rates treatments. More recently, owing detailed pathologic examination and knowledge gained monitor outcomes, appreciation limitations evolved. The recent momentum encouraged use early, multimodality in locally invasive cancer. scope chapter will encompass following: 1. A contemporary classification cancer. 2. The most data T3, relative various risk groups cancers. 3. Recent on expanding role adjuvant hormonal (AHT). 4. A critique therapies (or therapies), which have used treat failures these cancers.
springer.com
sci-hub.st 参考文章(64)
Roger M Macklis, Craig Zippe, John H. Suh, Jerald Katcher, Howard Levin, Eric Klein, Patrick Kupelian, External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. The cancer journal from Scientific American. ,vol. 3, pp. 78- 87 ,(1997)
William J. Catalona, Deborah S. Smith, 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer Journal of Urology. ,vol. 152, pp. 1837- 1842 ,(1994) , 10.1016/S0022-5347(17)32397-2
Jonathan I. Epstein, Marne J. Carmichael, Galina Pizovt, Patrick C. Walsh, Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup The Journal of Urology. ,vol. 150, pp. 135- 141 ,(1993) , 10.1016/S0022-5347(17)35415-0
A W Partin, P C Walsh, J I Epstein, C R Pound, J Q Clemens, Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years Urologic Clinics of North America. ,vol. 20, pp. 713- 725 ,(1993) , 10.1016/S0094-0143(21)00924-1
Forman Jd, Velasco J, THERAPEUTIC RADIATION IN PATIENTS WITH A RISING POST-PROSTATECTOMY PSA LEVEL Oncology. ,vol. 12, pp. 33- 39 ,(1998)
Horst Zincke, Joseph E. Oesterling, Michael L. Blute, Erik J. Bergstralh, Robert P. Myers, David M. Barrett, Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer Journal of Urology. ,vol. 152, pp. 1850- 1857 ,(1994) , 10.1016/S0022-5347(17)32399-6
Alan W. Partin, John Yoo, H. Ballentine Carter, Jay D. Pearson, Daniel W. Chan, Jonathan I. Epstein, Patrick C. Walsh, The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer The Journal of Urology. ,vol. 150, pp. 110- 114 ,(1993) , 10.1016/S0022-5347(17)35410-1
G D Chisholm, R F Deane, G B McKelvie, C D Rennie, E L Gilliland, C P Chilton, M G Royle, N H Townell, J Breakey, S M Cresswell, J Glaholm, G M Sole, J J Bolger, M J Stower, M H Ashken, D A Tolley, F J Bramble, P A Jones, R A Styles, Moffat Lef., R W Glashan, Rhind, A Radley, G J Fellows, J Crowther, B Hafner, S Knight, E Thompson, J Smith, J Burrett, P B Clark, J Boreham, R Peto, L N Jurczyk, B A DeSousa, S Parish, Logie Jrc., Ross Rta., Cox, K Perry, T P Stephenson, K K Sethia, Turner Dtl., M Davies, Harrison Gsm., G F Carswell, Rogers Acn., M Lucas, M R Heal, V Boag, J Hetherington, D Kirk, Charlton Cac., Shepheard Bgf., N A Green, M F Smith, T B Hargreave, Moore Kth., R J Morgan, K N Bullock, Bevis Cra., J B Anderson, A L Stewart, Newling Dwk., B Richards, Grayson Cea., Gaches Cgc., P T Doyle, Robinson Mrg., S Sagar, R J Shearer, C M Evans, R A Jones, Wightman Jak., E R Coulton, J C Smith, M E French, C S Powell, Fernie Cgm., Orr Pgg., M Claridge, Gallegos Crr., G H Urwin, G M Watson, C Roberts, S Griffin, M B Rose, M Fordham, G S Watson, W T Lawrence, R Pollard, P H Smith, M J James, Grant Jbp., J P Ward, R R Hall, M Hehir, J L Williams, R W Thomson, L L Beynon, R J Luck, R Rampling, R S Adib, P English, A McGregor, C D Baumber, J W Blaxland, M H Devereux, R Clack, Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial BJUI. ,vol. 79, pp. 235- 246 ,(1997)
A.L. Zietman, J.J. Coen, W.U. Shipley, C.G. Willett, J.T. Efird, Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome The Journal of Urology. ,vol. 151, pp. 640- 645 ,(1994) , 10.1016/S0022-5347(17)35036-X
Ying Z. Grasso, Craig D. Zippe, Manjula K. Gupta, Howard S. Levin, Eric A. Klein, Combined Nested RT-PCR Assay for Prostate-specific Antigen and Prostate-specific Membrane Antigen in Prostate Cancer Patients: Correlation with Pathological Stage Cancer Research. ,vol. 58, pp. 1456- 1459 ,(1998)